Vaccine Ranking
PCV for high-risk groups and RSV ranked highest for mortality impact. HPV's high priority was mainly linked to effectiveness, durability, complications, and DALY-related impact rather than antimicrobial-use reduction or incidence. HPV was…
1 sources - 6 claims
PCV for high-risk groups and RSV ranked highest for mortality impact. HPV's high priority was mainly linked to effectiveness, durability, complications, and DALY-related impact rather than antimicrobial-use reduction or incidence. HPV was the strongest overall candidate and ranked first in half of the importance and feasibility criteria. RSV and varicella were not recommended for introduction within the next five years. RSV and chickenpox performed poorly on price, market availability, and funding sustainability.